Prime Medicine, Inc..
PRME.US | Research and experimental development on natural sciences and engineering
Prime Medicine, Inc. is a biotechnology company dedicated to creating and delivering a new class of gene therapy, Prime Editing, to patients. Prime Editing is a versatile gene editing technology that can precisely correct disease-causing genes. The company is focused on developing Prime Editing ther...Show More
Better Health for All
20
Prime Medicine's core business is developing one-time curative genetic therapies using Prime Editing, a technology with the potential to repair almost all types of genetic mutations.
1
The company is progressing a diversified portfolio of eighteen programs focused on genetic diseases, cancers, immune diseases, and other conditions, aiming to deliver transformative health benefits.
2
The company's R&D expenses were $30.9 million for the three months ended March 31, 2023, compared to $13.7 million for the same period in 2022.
3
Prime Medicine has received two U.S. patents for its Prime Editing technology in April and May 2023.
4
The company is preparing its first treatments for clinical trials and plans to initiate IND-enabling studies for PM359 in chronic granulomatous disease in 2023.
5
Fair Money & Economic Opportunity
0
Prime Medicine, Inc. is a clinical-stage biotechnology company focused on gene editing therapeutics.
1
The provided articles detail its financial metrics, stock performance, and IPO. There is no evidence that the company engages in lending, insuring, moving, or storing money, nor does it offer any consumer financial products or services. Therefore, all KPIs related to Fair Money & Economic Opportunity are not applicable to Prime Medicine's core business operations.
Fair Pay & Worker Respect
0
No specific, quantifiable evidence was found in the provided articles for any of the KPIs related to Fair Pay & Worker Respect. Information regarding living wage coverage, CEO to median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, voluntary turnover rate, labor violation incidents, insecure contract share, or health insurance coverage was not available.
1
While employee counts and a workforce reduction were mentioned, these do not directly provide the voluntary turnover rate.
2
The company's Code of Business Conduct and Ethics outlines policies but does not report on the number of substantiated labor law violations.
3
Fair Trade & Ethical Sourcing
0
No evidence available to assess Prime Medicine, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess Prime Medicine, Inc. on Honest & Fair Business.
Kind to Animals
0
No evidence available to assess Prime Medicine, Inc. on Kind to Animals.
No War, No Weapons
0
No evidence available to assess Prime Medicine, Inc. on No War, No Weapons.
Planet-Friendly Business
0
The provided articles pertain to 'Prime Healthcare' and 'Prime Inc.', not 'Prime Medicine, Inc. (PRME.US)', the company specified for assessment.
1
As such, no relevant evidence for any of the Planet-Friendly Business KPIs could be extracted for Prime Medicine, Inc.
2
All KPIs are therefore omitted due to a lack of specific, concrete data points for the company under review.
Respect for Cultures & Communities
0
No evidence available to assess Prime Medicine, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No specific, concrete evidence was found in the provided articles pertaining to Prime Medicine, Inc. (PRME.US) for any of the Safe & Smart Tech KPIs. The articles that mention "Prime" refer to "Prime Healthcare," which is a distinct entity from Prime Medicine, Inc.
1
Zero Waste & Sustainable Products
0
No specific, quantitative data points were found in the provided articles to assess Prime Medicine, Inc. (PRME.US) against any of the 'Zero Waste & Sustainable Products' KPIs. One article discussed Prime Therapeutics, a different entity.
1
The other two articles about Prime Medicine (PRME.US) focused on strategic restructuring
2
and a job description for an EH&S Manager
3
, neither of which contained relevant performance metrics for waste management, product sustainability, or other related initiatives.